FORMULATIONS OF ANTI-GM-CSFRALPHA MONOCLONAL ANTIBODY

FORMULATIONS OF ANTI-GM-CSFRALPHA MONOCLONAL ANTIBODY

The present invention provides a formulation comprising: (i) a monoclonal antibody; and (ii) an ionic excipient; wherein the monoclonal antibody is present at a concentration of about 50mg/ml or greater (e.g. about 50 mg/ml to about 200 mg/ml) and the ionic excipient is present at a concentration of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHAH, Ambarish Umakant, LOBO, Brian Andrew, SHARMA, Monika Sood, GOLDBERG, Deborah Sweet
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SHAH, Ambarish Umakant
LOBO, Brian Andrew
SHARMA, Monika Sood
GOLDBERG, Deborah Sweet
description The present invention provides a formulation comprising: (i) a monoclonal antibody; and (ii) an ionic excipient; wherein the monoclonal antibody is present at a concentration of about 50mg/ml or greater (e.g. about 50 mg/ml to about 200 mg/ml) and the ionic excipient is present at a concentration of about 50 to about 150 mM and the formulation has a pH of 5.5 to 6.5.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3797792A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3797792A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3797792A13</originalsourceid><addsrcrecordid>eNrjZDB18w_yDfVxDPH09wtW8HdTcPQL8dR199V1DnYLcvQJ8HBU8PX383f28fdz9AFLOvm7RPIwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXAGNzS3NzSyNHQ2MilAAAuS4njg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FORMULATIONS OF ANTI-GM-CSFRALPHA MONOCLONAL ANTIBODY</title><source>esp@cenet</source><creator>SHAH, Ambarish Umakant ; LOBO, Brian Andrew ; SHARMA, Monika Sood ; GOLDBERG, Deborah Sweet</creator><creatorcontrib>SHAH, Ambarish Umakant ; LOBO, Brian Andrew ; SHARMA, Monika Sood ; GOLDBERG, Deborah Sweet</creatorcontrib><description>The present invention provides a formulation comprising: (i) a monoclonal antibody; and (ii) an ionic excipient; wherein the monoclonal antibody is present at a concentration of about 50mg/ml or greater (e.g. about 50 mg/ml to about 200 mg/ml) and the ionic excipient is present at a concentration of about 50 to about 150 mM and the formulation has a pH of 5.5 to 6.5.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210331&amp;DB=EPODOC&amp;CC=EP&amp;NR=3797792A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210331&amp;DB=EPODOC&amp;CC=EP&amp;NR=3797792A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHAH, Ambarish Umakant</creatorcontrib><creatorcontrib>LOBO, Brian Andrew</creatorcontrib><creatorcontrib>SHARMA, Monika Sood</creatorcontrib><creatorcontrib>GOLDBERG, Deborah Sweet</creatorcontrib><title>FORMULATIONS OF ANTI-GM-CSFRALPHA MONOCLONAL ANTIBODY</title><description>The present invention provides a formulation comprising: (i) a monoclonal antibody; and (ii) an ionic excipient; wherein the monoclonal antibody is present at a concentration of about 50mg/ml or greater (e.g. about 50 mg/ml to about 200 mg/ml) and the ionic excipient is present at a concentration of about 50 to about 150 mM and the formulation has a pH of 5.5 to 6.5.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB18w_yDfVxDPH09wtW8HdTcPQL8dR199V1DnYLcvQJ8HBU8PX383f28fdz9AFLOvm7RPIwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXAGNzS3NzSyNHQ2MilAAAuS4njg</recordid><startdate>20210331</startdate><enddate>20210331</enddate><creator>SHAH, Ambarish Umakant</creator><creator>LOBO, Brian Andrew</creator><creator>SHARMA, Monika Sood</creator><creator>GOLDBERG, Deborah Sweet</creator><scope>EVB</scope></search><sort><creationdate>20210331</creationdate><title>FORMULATIONS OF ANTI-GM-CSFRALPHA MONOCLONAL ANTIBODY</title><author>SHAH, Ambarish Umakant ; LOBO, Brian Andrew ; SHARMA, Monika Sood ; GOLDBERG, Deborah Sweet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3797792A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SHAH, Ambarish Umakant</creatorcontrib><creatorcontrib>LOBO, Brian Andrew</creatorcontrib><creatorcontrib>SHARMA, Monika Sood</creatorcontrib><creatorcontrib>GOLDBERG, Deborah Sweet</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHAH, Ambarish Umakant</au><au>LOBO, Brian Andrew</au><au>SHARMA, Monika Sood</au><au>GOLDBERG, Deborah Sweet</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FORMULATIONS OF ANTI-GM-CSFRALPHA MONOCLONAL ANTIBODY</title><date>2021-03-31</date><risdate>2021</risdate><abstract>The present invention provides a formulation comprising: (i) a monoclonal antibody; and (ii) an ionic excipient; wherein the monoclonal antibody is present at a concentration of about 50mg/ml or greater (e.g. about 50 mg/ml to about 200 mg/ml) and the ionic excipient is present at a concentration of about 50 to about 150 mM and the formulation has a pH of 5.5 to 6.5.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3797792A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title FORMULATIONS OF ANTI-GM-CSFRALPHA MONOCLONAL ANTIBODY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T21%3A03%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHAH,%20Ambarish%20Umakant&rft.date=2021-03-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3797792A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true